谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and Safety of Alectinib in ALK-positive Non-Small Cell Lung Cancer and Blood Markers for Prognosis and Efficacy: a Retrospective Cohort Study

Yingying Jiang,Yue Shi,Yiling Liu,Zihan Wang,Yuxin Ma, Xinhong Shi, Lin Lu,Zhitong Wang,Hang Li,Yushu Zhang,Caolu Liu, Shaorui Zhang, Zhihao Zhong,Jianwei Lu,Meiqi Shi,Bo Shen,Guoren Zhou,Rong Yin,Domenico Galetta,Anna Grenda,Atocha Romero,Brett G. M. Hughes,Cheng Chen,Xiaohua Wang,Jifeng Feng

Translational lung cancer research（2022）

引用 2|浏览29
暂无评分
关键词
Non-small cell lung cancer (NSCLC),ALK-positive,alectinib,adverse drug reaction (ADR),biomarkers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要